mRNA technology

Statistics report on the mRNA technology

mRNA technology

This report presents a range of statistics and facts about the mRNA (messenger ribonucleic acid) technology. It is well-known to the broader public due to the COVID-19 vaccines from Moderna and BioNTech/Pfizer, which are mostly used in the Western world. The report provides a good starting point to get to know the mRNA landscape, including its position within biotech, top companies, short-term and long-term outlooks, etc.

Download your Report

  We value your privacy and will never rent or sell your email address.

Privacy

Table of contents

Overview

5
  • Basic Statistic Global pharmaceutical revenue by technology 2012-2026
  • Basic Statistic Percentage of global pharmaceutical sales by technology 2014-2028
  • Basic Statistic Top pharma and biotech companies by net sales growth in 2022
  • Basic Statistic Top 50 global pharmaceutical and biotech companies by R&D intensity in 2022
  • Premium Statistic Forecasted revenue of mRNA market revenue worldwide 2021-2035

Research and development

5
  • Premium Statistic Global funding in mRNA therapeutics and vaccines 2015-2020
  • Premium Statistic Clinical pipeline of mRNA therapeutics worldwide by therapy area 2021
  • Basic Statistic Clinical pipeline of mRNA prophylactic vaccines worldwide by therapy area 2021
  • Basic Statistic Clinical pipeline of mRNA therapeutic vaccines worldwide by therapy area 2021
  • Premium Statistic mRNA technology clinical pipelines worldwide by therapy area and stage 2021

COVID-19

6
  • Basic Statistic Forecasted COVID-19 vaccine share of total mRNA revenues globally 2021-2035
  • Premium Statistic Forecasted COVID-19 vaccine revenue share globally by technology 2026
  • Basic Statistic Bestselling COVID-19 vaccines and drugs worldwide in 1st HY 2021
  • Basic Statistic Drugs generating 10 billion U.S. dollars or more in annual sales worldwide 2021
  • Basic Statistic Forecasted sales of select COVID-19 vaccines worldwide 2021-2022
  • Premium Statistic COVID-19 vaccine development, enrollment and funding status July 28, 2020, by company

Leading companies

4
  • Premium Statistic Leading mRNA biotech companies' revenues 2022
  • Basic Statistic Leading mRNA biotech companies' net income 2022
  • Basic Statistic Leading mRNA biotech companies' R&D spending 2022
  • Basic Statistic Leading mRNA biotech companies' market cap 2023

Focus: Moderna

5
  • Basic Statistic Moderna's revenue 2016-2023
  • Basic Statistic Moderna net income 2016-2023
  • Basic Statistic R&D expenses of Moderna 2016-2023
  • Basic Statistic Moderna total assets 2016-2023
  • Basic Statistic Net Present Value of Moderna products worldwide 2021

Focus: BioNTech

4
  • Basic Statistic Revenue of BioNTech 2017-2023
  • Basic Statistic Operating income of BioNTech 2017-2023
  • Basic Statistic Earnings per share of BioNTech 2017-2023
  • Basic Statistic Total assets of BioNTech 2017-2023
Report this content
FURTHER REPORTS

Recommended and recent reports

  • Biotechnology in Germany
  • BioNTech
  • BioNTech - 2023 Form 20-F
  • Biotechnology in Spain
  • Beyond Borders - Biotechnology Report 2023
  • Biotechnology industry in Europe
  • Moderna Inc.
  • Vaccine industry in China
  • How Australia Can Build A Stronger Biotechnology Industry
  • Evaluate Vantage 2024 Preview
  • Chinese COVID-19 vaccines
  • Deutscher Biotechnologie-Report 2023
  • Biopharma and Medtech 2022 Review
  • The U.S. Bioscience Industry 2022
  • Monsanto-Bayer
  • EP Vantage Pharma & Biotech 2018 Preview
  • Pharmaceutical & Biotech Sales Analysis by Country - Top Drugs, Top Regions
  • Biogen
  • Roche
  • Amgen

Recommended statistics

You may also be interested in...

Statista report shop

Explore all Statista reports

We provide information on industries, companies, consumers, trends, countries, and politics, covering the latest and most important issues in a condensed format.

Statista report shop Go to reports

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)
Email
support@statista.com

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)
Email
asia.support@statista.com

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)
Email
asia.support@statista.com

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)
Email
eu.support@statista.com

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)
Email
latam@statista.com

Mon - Fri, 9am - 6pm (EST)

Menu